About ProPharma
ProPharma is a company based in Leiden (Netherlands) founded in 1990 was acquired by ProPharma Group in July 2018. It operates as a Professional Services and Managed Services. ProPharma offers products and services including Regulatory Sciences Consulting, Clinical Research Solutions, Pharmacovigilance Solutions, Medical Information Services, and Digital Transformation Services. ProPharma operates in a competitive market with competitors including Blue Matter Consulting, MCRA, PharmAla Biotech, S-Cubed and CATALIS, among others.
- Headquarter Leiden, Netherlands
- SectorsHealthcare
- Phone•••• ••••
- Website xendo.com
- Social LinkedIn X Instagram
- Acquired by ProPharma Group (Jul 2018)
- Legal Name Propharma Group Mis Limited
- InvestorsProPharma Group
& 2 more
- Acquired by
Products & Services of ProPharma
ProPharma offers a comprehensive portfolio of products and services, including Regulatory Sciences Consulting, Clinical Research Solutions, Pharmacovigilance Solutions, Medical Information Services, and Digital Transformation Services.
Support is provided for drug regulatory lifecycle management.
Clinical development support is offered for various therapies.
Safety monitoring is ensured throughout product lifecycle stages.
Accurate medical information is delivered via contact centers.
Technology solutions are implemented for life sciences projects.
Investors in ProPharma
ProPharma has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include ProPharma Group, QPS and Sovereign Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment partnerships are formed with service-based businesses for growth. | – | sovereigncapital.co.uk | London, United Kingdom | |
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device | 2001 | propharmagroup.com | Saint Paul, United States | |
Contract research organisation offering drug discovery, preclinical and clinical development services | 1995 | qps.com | Newark, United States |
Investor details for ProPharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ProPharma
4 dated milestones of ProPharma across 28 years, from founding to its latest funding, stage changes and deals.
- Founded ProPharma is founded.
- Exit Acquired by QPS.
- Exit Acquired by Sovereign Capital.
- Exit Acquired by ProPharma Group.
Competitors of ProPharma
ProPharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Matter Consulting, MCRA, PharmAla Biotech, S-Cubed and CATALIS, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bluematterconsulting.com | 2012 | San Francisco, United States | – | 98 | Provider of consulting services focused for clinical drug development | |
| mcra.com | 2004 | New York, United States | – | – | Provider of regulatory, quality assurance and market access services to biopharma sector | |
| pharmala.ca | 2021 | Toronto, Canada | – | – | Biomanufacturing, regulatory, and financial services are provided by PharmAla Biotech. | |
| s-cubed-global.com | 2007 | Copenhagen, Denmark | – | 44 | Specialized consulting in clinical biometrics and regulatory affairs is provided. | |
| catalisquebec.com | 2017 | Montreal, Canada | $1.18M | – | Consulting services for clinical drug development and trials are provided. | |
| aptusclinical.com | 2014 | Stockport, United Kingdom | – | – | Auxiliary clinical development services are provided to biopharmaceutical firms. | |
| pushkang.com.cn | 2014 | Shaoxing, China | $15.49M | – | R&D and consulting service company developing immunity, biochemical and, molecular diagnostic kits | |
| ask-pharm.com | 2003 | Nanjing, China | – | – | Drug research and development services are manufactured and provided. | |
| xendo.nl | 1990 | Leiden, Netherlands | – | – | Strategic consulting services are provided to clients by Xendo. |
Detailed competitors of ProPharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProPharma
Websites that share an audience with ProPharma (xendo.com).
Websites whose visitors overlap most with ProPharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sterislifesciences.com | sterislifesciences.com | 100% | – | #1,136,753 | – |
| xen.do | 48% | – | – | View details |
Latest news on Propharma
Complete news archive for ProPharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ProPharma
10 companies that operate in the same segment as ProPharma (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ProPharma
ProPharma was founded in 1990.
ProPharma is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
ProPharma is involved in delivering comprehensive consulting services across the pharmaceutical, biotechnology, and medical device sectors. Specialized solutions are offered in regulatory sciences, clinical research, pharmacovigilance, quality compliance, and medical information. Support is provided throughout the product lifecycle, from early development to post-market stages. Services are tailored to navigate complex regulatory challenges and ensure compliance with global standards. Expertise is extended to therapeutic areas such as oncology, rare diseases, and cell and gene therapy. A global presence is maintained to assist clients in bringing innovative therapies to market efficiently.
ProPharma's top competitors include S-Cubed, Blue Matter Consulting and PharmAla Biotech.
ProPharma offers Regulatory Sciences Consulting, Clinical Research Solutions, Pharmacovigilance Solutions, Medical Information Services, and Digital Transformation Services.
ProPharma has 3 investors. Key investors include ProPharma Group, QPS, and Sovereign Capital.
ProPharma operates through Propharma Group Mis Limited.
Yes. ProPharma was acquired by ProPharma Group in July 2018.